DexCom Reports Fourth Quarter And Full Year 2013 Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DexCom, Inc. (Nasdaq: DXCM) today reported its audited financial results as of and for the quarter and fiscal year ended December 31, 2013.

For the full-year ended December 31, 2013, product revenue grew to $157.1 million, an increase of 69% from the $93.0 million in product revenue reported for 2012, and total revenue grew to $160.0 million, an increase of 60% from 2012.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC